Disc Medicine IRON
NASDAQ IRON
$64.27 +0.66 (+1.04%)
As of: Oct 2, 2026 · 1:50 PM EDT

Disc Medicine (IRON) Cash from Financing Activities (2020 - 2026)

Updated

Disc Medicine's Cash from Financing Activities was $32.34 million in Q2 2026, compared with $892,000 a year earlier.

Analysis

Disc Medicine (IRON) Cash from Financing Activities (2020 - 2026) Analysis & Trends

On a trailing twelve-month basis, Disc Medicine's Cash from Financing Activities was $262.3 million through Jun 30, 2026, down 4.4% year-over-year; for FY2025, it came in at $473.41 million, up 116.8% from FY2024.

  • Cash from Financing Activities shows a five-year compound annual growth rate of 31.1% (FY2020 to FY2025).
  • In earlier years, Cash from Financing Activities was $218.31 million in FY2024 (-8.8%), $239.38 million in FY2023 (+60.7%), $148.98 million in FY2022 (+65.7%) and $89.93 million in FY2021 (-26.5%).
  • Quarterly Cash from Financing Activities has moved between -$102.73 million (Q4 2021) and $244.25 million (Q1 2025) over five years.
  • Compared with a year earlier, Cash from Financing Activities was higher in two of the last five quarters, with growth averaging 143.5%.
  • The best year-over-year quarter for Cash from Financing Activities over five years was Q4 2025 (growth of 652.4%); the worst was Q1 2022 (a decline of 100.0%).
  • Per Business Quant data, IRON's Cash from Financing Activities in the three quarters before Q2 2026 was $1.7 million (Q1 2026), $216.68 million (Q4 2025) and $11.59 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -8.78 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -5.05 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 1.76 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -2.02 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -47.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -1.48 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 2.34 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -3.66 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -426.70 Mn
10 Disc Medicine 2.51 Bn 2.51 Bn - 32.34 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 32.34 Mn
Mar 31, 2026 1.70 Mn
Dec 31, 2025 216.68 Mn
Sep 30, 2025 11.59 Mn
Jun 30, 2025 892,000.00
Mar 31, 2025 244.25 Mn
Dec 31, 2024 28.80 Mn
Sep 30, 2024 426,000.00
Jun 30, 2024 173.19 Mn
Mar 31, 2024 15.90 Mn
Dec 31, 2023 7.76 Mn
Sep 30, 2023 460,000.00
Jun 30, 2023 153.86 Mn
Mar 31, 2023 77.31 Mn
Dec 31, 2022 148.82 Mn
Sep 30, 2022 22,000.00
Jun 30, 2022 86,000.00
Mar 31, 2022 55,000.00
Dec 31, 2021 -102.73 Mn
Sep 30, 2021 -1.25 Mn
API Access

Disc Medicine Cash from Financing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=IRON&period=max&api_key=YOUR_API_KEY